Home > Healthcare > Medical Devices > Therapeutic Devices > Insulin Pump Market

Insulin Pump Market Share

Report ID: GMI7983
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Insulin Pump Market Share

These players are innovating their products and services to stay competitive. They are expanding their global reach through strategic partnerships and acquisitions. In addition, these companies are diversifying their offerings and exploring emerging markets to sustain growth and meet the evolving patient needs.

Insulin Pump Market Companies

Some of the major insulin pump industry contenders are:

Debiotech S.A.
F. Hoffmann La
Insulet Corporation
Lenomed Medical
Nipro Corporation
Medtronic plc
Roche AG
MicroPort
Scientific Corporation
Tandem Diabetic Care Inc.
Terumo Corporation
ViCentra B.V.
Ypsomed

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The insulin pump market size was valued at over USD 5.2 billion in 2023 and is expected to witness 12.4% CAGR from 2024 to 2032, led by increasing collaborations with technology firms, research institutions, and healthcare providers to enhance device innovation.

The home care segment of market held a robust growth in 2023 and is expected to record 12.7% CAGR through 2032, due to increasing usage at homes for providing patients with greater autonomy in managing their diabetes.

North America insulin pump market held a decent market share in 2023 and is predicted to record over USD 6 billion by 2032, due to the rising geriatric population and supportive reimbursement policies.

Debiotech S.A., F. Hoffmann La, Insulet Corporation, Lenomed Medical, Nipro Corporation, Medtronic plc, Roche AG, MicroPort , Scientific Corporation among others.